This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baucheron, S.
Right arrow Articles by Butaye, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baucheron, S.
Right arrow Articles by Butaye, P.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2005, p. 862-863, Vol. 49, No. 2
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.2.862-863.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

High-Level Resistance to Fluoroquinolones Linked to Mutations in gyrA, parC, and parE in Salmonella enterica Serovar Schwarzengrund Isolates from Humans in Taiwan


arrow
LETTER
 
Recent reports suggest high-level fluoroquinolone (FQ) resistance is emerging in Salmonella enterica serovar Typhimurium, S. enterica serovar Choleraesuis, and S. enterica serovar Schwarzengrund in different parts of the world (1-9).

In this study we analyzed high-level FQ resistance mechanisms in four S. enterica serovar Schwarzengrund strains which showed resistance levels to ciprofloxacin (Cip) MICs of 16 or 64 µg/ml and were isolated from stools or blood from patients in Taiwan (Table 1). Three of them were also multidrug resistant (Table 1).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Characteristics of the S. enterica serovar Schwarzengrund strains studied

Strains CGST2, CGST3, CGST4, and CGST5 carried up to five mutations in the quinolone target genes relative to those from S. enterica serovar Typhimurium, i.e., all carried a double mutation in the quinolone resistance-determining region (QRDR) of gyrA, leading to amino acid changes Ser83Phe and Asp87Asn or Asp87Gly, and a double mutation in the QRDR of parC, leading to amino acid changes Thr57Ser and Ser80Arg or Glu84Lys. Two strains displaying the highest levels of resistance to Cip carried an additional single mutation in the QRDR of parE, leading to amino acid change Ser458Pro. The ParC Thr57Ser amino acid change is likely not involved in quinolone resistance, because it was also identified in quinolone-susceptible S. enterica serovar Schwarzengrund control strain 383SA99 (Table 1). This amino acid change was, however, recently reported to be involved in decreased FQ susceptibility of S. enterica strains isolated in Hong Kong (7). Because we also found this amino acid change in a quinolone-susceptible S. enterica serovar Hadar strain (Table 1), it is probably the result of genetic divergence between the parC genes of S. enterica serovar Typhimurium, serovar Schwarzengrund, and serovar Hadar rather than being related to quinolone resistance. The ParC Ser80Arg and Glu84Lys amino acid changes found in the FQ-resistant S. enterica serovar Schwarzengrund strains have also been recently reported in FQ-resistant serovar Typhimurium isolates from patients in France, Hong Kong, Japan, and Taiwan (3, 6, 7, 8). The ParE Ser458Pro amino acid change found in strains CGST2 and CGST4 was also recently reported for FQ-resistant S. enterica serovar Typhimurium isolates from patients in Hong Kong (7). According to our data, this amino acid change, which is located at a same position as that found in the homologous GyrB protein (amino acid change Ser464Phe in FQ-resistant S. enterica serovar Typhimurium DT204 [2]), could account for a two- to fourfold increase in resistance levels to FQs (Table 1). The use of the efflux pump inhibitor Phe-Arg-ß-naphthylamide (PAßN) decreased the FQ resistance levels 2- to 64-fold depending on FQ and the strain, suggesting participation of efflux in high-level FQ resistance (Table 1). The combination PAßN-enrofloxacin was the most effective in decreasing the resistance levels, as previously demonstrated (2).

In conclusion, high-level FQ resistance in S. enterica serovar Schwarzengrund strains appears to be linked to multiple target gene mutations at codon positions 83 and 87 for gyrA, codon positions 80 and 84 for parC, and codon position 458 for parE, as well as being linked to active efflux.


arrow
ACKNOWLEDGMENTS
 
We thank C. Mouline and V. Verbeeren for expert technical assistance.

This study was funded by INRA, projet Transversalité.


arrow
REFERENCES
 
    1
  1. Baucheron, S., E. Chaslus-Dancla, and A. Cloeckaert. 2004. Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204. J. Antimicrob. Chemother. 53:657-659.[Abstract/Free Full Text]
    2. 2
  2. Baucheron, S., H. Imberechts, E. Chaslus-Dancla, and A. Cloeckaert. 2002. The AcrB multidrug transporter plays a major role in high-level fluoroquinolone resistance in Salmonella enterica serovar Typhimurium phage type DT204. Microb. Drug Resist. 8:281-289.[CrossRef][Medline]
    3. 3
  3. Casin, I., J. Breuil, J.P. Darchis, C. Guelpa, and E. Collatz. 2003. Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica Typhimurium isolates in humans. Emerg. Infect. Dis. 9:1455-1457.[Medline]
    4. 4
  4. Chiu, C. H., T. L. Wu, L.H. Su, J. W. Liu, and C. Chu. 2004. Fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis, Taiwan, 2000-2003. Emerg. Infect. Dis. 10:1674-1676.[Medline]
    5. 5
  5. Guerra, B., B. Malorny, A. Schroeter, and R. Helmuth. 2003. Multiple resistance mechanisms in fluoroquinolone-resistant Salmonella isolates from Germany. Antimicrob. Agents Chemother. 47:2059.[Free Full Text]
    6. 6
  6. Hsueh, P. R., L. J. Teng, S.P. Tseng, C.F. Chang, J.H. Wan, J.J. Yan, C.M. Lee, Y.C. Chuang, W.K. Huang, D. Yang, J.M. Shyr, K.W. Yu, L.S. Wang, J.J. Lu, W.C. Ko, J.J. Wu, F.Y. Chang, Y.C. Yang, Y.J. Lau, Y.C. Liu, C.Y. Liu, S.W. Ho, and K. T. Luh. 2004. Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from pigs to humans, Taiwan. Emerg. Infect. Dis. 10:60-68.[Medline]
    7. 7
  7. Ling, J. M., E. W. Chan, A.W. Lam, and A. F. Cheng. 2003. Mutations in topoisomerase genes of fluoroquinolone-resistant Salmonellae in Hong Kong. Antimicrob. Agents Chemother. 47:3567-3573.[Abstract/Free Full Text]
    8. 8
  8. Nakaya, H., A. Yasuhara, K. Yoshimura, Y. Oshihoi, H. Izumiya, and H. Watanabe. 2003. Life-threatening infantile diarrhea from fluoroquinolone-resistant Salmonella enterica Typhimurium with mutations in both gyrA and parC. Emerg. Infect. Dis. 9:255-257.[Medline]
    9. 9
  9. Olsen S.J., E.E. DeBess, T.E. McGivern, N. Marano, T. Eby, S. Mauvais, V.K. Balan, G. Zirnstein, P.R. Cieslak, and F.J. Angulo. 2001. A nosocomial outbreak of fluoroquinolone-resistant Salmonella infection. N. Engl. J. Med. 344:1572-1579.[Abstract/Free Full Text]
Sylvie Baucheron
Elisabeth Chaslus-Dancla
Axel Cloeckaert*
Unité BioAgresseurs
Santé et Environnement
Institut National de la Recherche Agronomique,
37380 Nouzilly
France

Cheng-Hsun Chiu
Department of Pediatrics
Chang Gung Children's Hospital
Kweishan, Taoyuan
Taiwan

Patrick Butaye
Centre d'Etude et de Recherches Vétérinaires et Agrochimiques
Brussels
Belgium

* Phone: 33 2 47 42 77 50
Fax: 33 2 47 42 77 74
E-mail: cloeckae{at}tours.inra.fr

Antimicrobial Agents and Chemotherapy, February 2005, p. 862-863, Vol. 49, No. 2
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.2.862-863.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Cavaco, L. M., Hasman, H., Xia, S., Aarestrup, F. M. (2009). qnrD, a Novel Gene Conferring Transferable Quinolone Resistance in Salmonella enterica Serovar Kentucky and Bovismorbificans Strains of Human Origin. Antimicrob. Agents Chemother. 53: 603-608 [Abstract] [Full Text]  
  • Kehrenberg, C., Friederichs, S., de Jong, A., Schwarz, S. (2008). Novel Variant of the qnrB Gene, qnrB12, in Citrobacter werkmanii. Antimicrob. Agents Chemother. 52: 1206-1207 [Full Text]  
  • Kehrenberg, C., de Jong, A., Friederichs, S., Cloeckaert, A., Schwarz, S. (2007). Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations. J Antimicrob Chemother 59: 886-892 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baucheron, S.
Right arrow Articles by Butaye, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baucheron, S.
Right arrow Articles by Butaye, P.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»